Treatment duration of brigatinib in patients enrolled in the international expanded access program (EAP)

被引：0
|
作者：
Lin, M. M. [1 ]
Pan, X. [1 ]
Hou, P. [1 ]
Allen, S. [1 ]
Baumann, P. [1 ]
Hochmair, M. J. [2 ,3 ]
机构：
[1] Millennium Pharmaceut Inc, Cambridge, MA USA
[2] Otto Wagner Spital, Dept Resp & Crit Care Med, Vienna, Austria
[3] Otto Wagner Spital, Ludwig Boltzmann Inst COPD & Resp Epidemiol, Vienna, Austria
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
108O
引用
收藏
页码：42 / 42
页数：1
相关论文
共 50 条
  • [41] SAFETY DATA FROM AN EXPANDED ACCESS PROGRAM (EAP) OF NIVOLUMAB (NIVO) IN COMBINATION WITH IPILIMUMAB (IPI) IN PATIENTS WITH ADVANCED MELANOMA (MEL)
    Chapman, Paul B.
    Sznol, Mario
    Lao, Christopher D.
    Gonzalez, Rene
    Daniels, Gregory A.
    Thompson, John A.
    Kudchadkar, Ragini R.
    Sharfman, William H.
    Atkins, Michael B.
    Pavlick, Anna C.
    Infante, Jeffrey R.
    Kim, Kevin B.
    Weber, Jeffrey S.
    Nair, Suresh
    Cowey, Lance
    Lipson, Evan J.
    Lee, Sue
    Avila, Alexandre
    Hodi, Stephen
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 119 - 119
  • [42] Safety data from an expanded access program (EAP) of nivolumab (NIVO) in combination with ipilimumab (IPI) in patients with advanced melanoma (MEL).
    Chapman, Paul B.
    Sznol, Mario
    Lao, Christopher
    Gonzalez, Rene
    Daniels, Gregory A.
    Thompson, John A.
    Kudchadkar, Ragini Reiney
    Sharfman, William Howard
    Atkins, Michael B.
    Pavlick, Anna C.
    Infante, Jeffrey R.
    Kim, Kevin
    Weber, Jeffrey S.
    Patel, Sapna Pradyuman
    Nair, Suresh
    Cowey, C. Lance
    Lipson, Evan J.
    Lee, Sue
    Avila, Alexandre
    Hodi, F. Stephen
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [43] Nivolumab in Advanced Non-Squamous NSCLC Patients with KRAS Mutations: Results from the Italian Expanded Access Program (EAP)
    Ardizzoni, A.
    Bidoli, P.
    Chiari, R.
    Bonomi, L.
    Turci, D.
    Landi, L.
    Toschi, L.
    De Tursi, M.
    Francini, G.
    Giordano, M.
    Alabiso, O.
    De Censi, A.
    Livi, L.
    Berruti, A.
    Minelli, M.
    Ricevuto, E.
    Illiano, A.
    Puppo, G.
    Delmonte, A.
    Galetta, D.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1804 - S1804
  • [44] Efficacy and safety data in elderly patients with metastatic renal cell carcinoma included in the nivolumab Expanded Access Program (EAP) in Italy
    Vitale, Maria Giuseppa
    Scagliarini, Sarah
    Galli, Luca
    Pignata, Sandro
    Lo Re, Giovanni
    Berruti, Alfredo
    Defferrari, Carlotta
    Spada, Massimiliano
    Masini, Cristina
    Santini, Daniele
    Ciuffreda, Libero
    Ruggeri, Enzo Maria
    Bengala, Carmelo
    Livi, Lorenzo
    Fagnani, Daniele
    Bonetti, Andrea
    Giustini, Lucio
    Hamzaj, Alketa
    Procopio, Giuseppe
    Caserta, Claudia
    Sabbatini, Roberto
    PLOS ONE, 2018, 13 (07):
  • [45] Pemetrexed alone or in combination with cisplatin in previously treated patients with malignant pleural mesothelioma (MPM): Outcomes of an expanded access program (EAP).
    Orlando, M
    Wozniak, A
    Janne, P
    Belani, CP
    Keohan, ML
    Ross, H
    Polikoff, J
    Mintzer, D
    Bloss, L
    Obasaju, C
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 664S - 664S
  • [46] CABAZITAXEL IN PATIENTS WITH ADVANCED CRPC AFTER DOCETAXEL-FAILURE. RESULTS OF EXPANDED PROGRAM ACCESS (EAP) IN SPAIN: SAFETY AND EFFICACY
    Castellano, D. E.
    Anton Aparicio, L. M.
    Esteban, E.
    Velasco, G.
    Perez, Q.
    Sanchez, A.
    Perez-Valderrama, B.
    Batista, N.
    ANNALS OF ONCOLOGY, 2012, 23 : 314 - 314
  • [47] Real-world treatment duration in ALK-positive non-small-cell lung cancer patients receiving brigatinib through the early access program
    Lin, Huamao M.
    Pan, Xiaoyun
    Hou, Peijie
    Allen, Susan
    Baumann, Pia
    Hochmair, Maximilian J.
    FUTURE ONCOLOGY, 2020, 16 (15) : 1031 - 1041
  • [48] Open-label study of pemetrexed alone or in combination with a platinum in chemonaive patients (pts) with malignant pleural mesothelioma (MPM): Results from the International Expanded Access Program (EAP)
    Manegold, Christian
    Santoro, Armando
    O'Brien, Mary E. r.
    Stahel, Rolf A.
    Nackaerts, Kristiaan
    Bass, Paul
    Paz-Ares, Luis
    Sundstrom, Stein
    Visseren-Grul, Carla
    Blatter, Johannes
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S371 - S371
  • [49] Implementation of Tofersen Expanded Access Program (EAP) in the US, The Cumulative Experience of Six Academic Centers.
    Ajroud-Driss, Senda
    Babu, Suma
    Harms, Matthew
    Shneider, Neil
    Quinn, Colin
    Arcila-Londono, Ximena
    Bucelli, Robert
    MUSCLE & NERVE, 2023, 68 : S59 - S60
  • [50] Cabozantinib in metastatic renal cell carcinoma (mRCC): Data from UK expanded access program (EAP)
    Lista, A. Gomez de Liano
    Venugopal, B.
    Fife, K.
    Symeonides, S.
    Vasudev, N. S.
    Rudman, S. M.
    Vohra, S.
    Khasati, L.
    Pettinger, C.
    Szabados, B.
    Morrison, L.
    Powles, T.
    Boleti, E.
    ANNALS OF ONCOLOGY, 2018, 29 : 317 - 317
12345